journal article Aug 01, 1973

Inhibition of angiotensin-converting enzyme by analogs of peptides fromBothrops jararaca venom

View at Publisher Save 10.1007/bf01930447
Topics

No keywords indexed for this article. Browse by subject →

References
43
[1]
L. T. Skeggs, W. H. Marsh, J. R. Kahn andN. P. Shumway, J. exp. Med.99, 275 (1954). 10.1084/jem.99.3.275
[2]
L. T. Skeggs, J. R. Kahn andN. P. Shumway, J. exp. Med.103, 295 (1956). 10.1084/jem.103.3.295
[3]
K. K. F. Ng andJ. R. Vane, Nature, Lond.218, 144 (1968). 10.1038/218144a0
[4]
C. G. Huggins andN. S. Thampi, Life Sci.7, 633 (1968). 10.1016/0024-3205(68)90086-6
[5]
M. Roth, A. F. Weitzman andY. Piquilloud, Experientia25, 1247 (1969). 10.1007/bf01897474
[6]
J. W. Aiken andJ. R. Vane, Nature, Lond.228, 30 (1970). 10.1038/228030a0
[7]
D. W. Cushman andH. S. Cheung, Biochim. biophys. Acta250, 261 (1971). 10.1016/0005-2744(71)90142-2
[8]
D. W. Cushman andH. S. Cheung inHypertension'72 (Eds. J. Genest andE. Koiw; Springer Verlag, Berlin 1972), p. 532.
[9]
Y. Piquilloud, A. Reinharz andM. Roth, Biochim. biophys. Acta206, 136 (1970). 10.1016/0005-2744(70)90090-2
[10]
Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung

D.W. Cushman, H.S. Cheung

Biochemical Pharmacology 1971 10.1016/0006-2952(71)90292-9
[11]
H. Y. T. Yang, E. G. Erdös andY. Levin, J. Pharmac. exp. Ther.177, 291 (1971).
[12]
R. Igic, E. G. Erdös, H. S. J. Yeh, K. Sorrells andT. Nakajima, Circulation Res.30, II-51 (1972).
[13]
Y. E. Elisseeva, V. N. Orekhovich, L. V. Pavlikhina andL. P. Alexeenko, Clin. chim. Acta31, 413 (1971). 10.1016/0009-8981(71)90412-8
[14]
R. L. Stevens, E. R. Micalizzi, D. C. Fessler andD. T. Pals, Biochemistry11, 2999 (1972). 10.1021/bi00766a011
[15]
Y. S. Bakhle, Nature, Lond.220, 919 (1968). 10.1038/220919a0
[16]
Y. S. Bakhle andA. M. Reynard, Nature, Lond., New Biol.229, 187 (1971). 10.1038/newbio229187a0
[17]
C. G. Huggins, R. J. Corcoran, J. S. Gordon, H. W. Henry andJ. P. John, Circulation Res.26, I-93 (1970).
[18]
L. J. Greene, J. M. Stewart andS. H. Ferreira, Pharmac. Res. Commun.1, 159 (1969). 10.1016/s0031-6989(69)80080-9
[19]
S. H. Ferreira, D. C. Bartelt andL. J. Greene, Biochemistry9, 2583 (1970). 10.1021/bi00815a005
[20]
M. A. Ondetti, N. J. Williams, E. F. Sabo, J. Pluščec, E. Weaver andO. Kocy inProgress in Peptide Research (Ed.S. Lande; Gordon and Breach, New York 1972), p. 251.
[21]
M. A. Ondetti, N. J. Williams, E. F. Sabo, J. Pluščec, E. R. Weaver andO. Kocy, Biochemistry10, 4033 (1971). 10.1021/bi00798a004
[22]
H. Kato andT. Suzuki, Experientia25, 694 (1969). 10.1007/bf01897565
[23]
H. Kato andT. Suzuki, Proc. Japan Acad.46, 176 (1969). 10.2183/pjab1945.46.176
[24]
H. Kato andT. Suzuki, Experientia26, 1205 (1970). 10.1007/bf01897966
[25]
H. Kato andT. Suzuki, Biochemistry10, 972 (1971). 10.1021/bi00782a007
[26]
Inhibition of homogeneous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararaca

H.S. Cheung, D.W. Cushman

Biochimica et Biophysica Acta (BBA) - Enzymology 1973 10.1016/0005-2744(73)90352-5
[27]
Y. S. Bakhle, Br. J. Pharmac.43, 252 (1971). 10.1111/j.1476-5381.1971.tb07176.x
[28]
Y. S. Bakhle, inHypertension'72 (Eds.J. Genest andE. Koiw; Springer Verlag, Berlin 1972), p. 541.
[29]
V. A. Alabaster andY. S. Bakhle, Circulation Res.30, II-72 (1972).
[30]
F. E. Dorer, J. R. Kahn, K. E. Lentz, M. Levine andL. T. Skeggs, Circulation Res.31, 356 (1972). 10.1161/01.res.31.3.356
[31]
H. Y. T. Yang andN. H. Neff, J. Neurochem.19, 2443 (1972). 10.1111/j.1471-4159.1972.tb01298.x
[32]
E. Ueda, T. Kokubu, H. Akutsu andY. Yamamura, Experientia27, 1020 (1971). 10.1007/bf02138854
[33]
G. E. Sander, D. W. West andC. G. Huggins, Biochim. biophys. Acta242, 662 (1971). 10.1016/0005-2744(71)90161-6
[34]
S. L. Engel, T. R. Schaeffer, B. I. Gold andB. Rubin, Proc. Soc. exp. Biol. Med.140, 240 (1972). 10.3181/00379727-140-36433
[35]
G. R. Keim, J. Kirpan, A. E. Peterson, B. F. Murphy, G. L. Hassert andJ. W. Poutsiaka, Proc. Soc. exp. Biol. Med.140, 149 (1972). 10.3181/00379727-140-36413
[36]
J. W. Aiken andJ. R. Vane, Circulation Res.30, 263 (1972). 10.1161/01.res.30.3.263
[37]
E. M. Krieger, H. C. Salgado, C. J. Assan, L. J. Greene andS. H. Ferreira, Lancet1, 269 (1971). 10.1016/s0140-6736(71)91005-1
[38]
L. J. Greene, A. C. M. Camargo, E. M. Krieger, J. M. Stewart, andS. H. Ferreira, Circulation Res.30, II-62 (1972).
[39]
J. M. Stewart, S. H. Ferreira andL. J. Greene, Biochem. Pharmac.20, 1557 (1971). 10.1016/0006-2952(71)90284-x
[40]
E. D. Miller, A. I. Samuels, E. Haber andA. C. Barger, Science177, 1108 (1972). 10.1126/science.177.4054.1108
[41]
M. A. Ondetti, J. Pluščec, E. R. Weaver, N. J. Williams, E. F. Sabo andO. Kocy inChemistry and Biology of Peptides (Ed.J. Meienhofer; Ann Arbor Science Publishers, Inc., Ann Arbor 1972), p. 525.
[42]
J. Pluščec, E. R. Weaver, N. J. Williams, E. F. Sabo, O. Kocy, andM. A. Ondetti, in Proc. of the 12th Europ. Peptide Symposium (Eds.H. Hanson andH. D. Jakubke; North Holland Publishing Company, Amsterdam 1972), in press.
[43]
Biochem. J.126, 773 (1972). 10.1042/bj1260773
Metrics
85
Citations
43
References
Details
Published
Aug 01, 1973
Vol/Issue
29(8)
Pages
1032-1035
License
View
Cite This Article
D. W. Cushman, J. Pluščec, N. J. Williams, et al. (1973). Inhibition of angiotensin-converting enzyme by analogs of peptides fromBothrops jararaca venom. Experientia, 29(8), 1032-1035. https://doi.org/10.1007/bf01930447
Related

You May Also Like

Hsp70 chaperones: Cellular functions and molecular mechanism

M. P. Mayer, B. Bukau · 2005

2,431 citations

Current knowledge on exosome biogenesis and release

Nina Pettersen Hessvik, Alicia Llorente · 2017

2,056 citations

Tumor angiogenesis: causes, consequences, challenges and opportunities

Roberta Lugano, Mohanraj Ramachandran · 2019

1,698 citations